The PGY2 oncology pharmacy residency at the University of Pittsburgh Medical Center (UPMC) is designed for the individual interested in developing specialized clinical expertise in pharmaceutical care for oncology patients. UPMC is the premier health system in western Pennsylvania, one of the most renowned academic medical centers in the United States. The oncology pharmacy resident will gain expertise in the management of a wide variety of patients, including oncologic, hematologic, and hematopoietic stem cell transplant patients, in all phases of their care, both inpatient and outpatient settings. The resident will gain expertise in the pathophysiology of various hematologic and oncologic malignancies, management of these malignancies from both a pharmacologic as well as non-pharmacologic perspective, treatment of oncologic emergencies, adverse reaction monitoring and management secondary to chemotherapy/biotherapy/immunotherapy, therapeutic drug monitoring, and management of drug interactions.
The resident will be integrally involved in research opportunities and education of students and other healthcare professionals. Through the Resident Research Series, the resident will identify a practice-related research project and mentor, learn about study design and implementation as well as complete a residency project suitable for publication. The Teaching Mastery Series allows residents to learn about various teaching methods as well as develop their skills as pharmacy educators and clinical preceptors. Many opportunities to present formal seminars, patient cases, journal clubs, and in-service education for UPMC staff occur throughout the year. The resident will gain experience in both didactic and experiential teaching and precepting at the University of Pittsburgh School of Pharmacy. Flexibility is provided to meet the individual resident's goals and objectives.
Program objectives include: (1) demonstrate proficiency, confidence, and compassion in providing direct patient care to a wide variety of oncology/hematology/stem cell transplant patients; (2) demonstrate professionalism and effective communication skills in all components of pharmacy practice; (3) optimize pharmacotherapy and safe medication practices; (4) provide effective education to healthcare professionals; and (5) apply clinical and outcomes research concepts to professional practice. Highly motivated individuals with a strong interest in oncology who are committed to providing optimal pharmaceutical care within a team-oriented setting are encouraged to apply.
All residents must be eligible for pharmacist licensure in the Commonwealth of Pennsylvania. Applications for Pharmacist License and Intern Registration are available.
Pennsylvania requires 1500 registered intern hours in order to be eligible for licensure. Of the 1500 hours, only 750 hours can be obtained through an academic program. That is, 750 intern hours must be obtained outside of school. These 750 intern hours must be registered with a state board of pharmacy to count toward licensure in Pennsylvania. If you have not yet started registering hours with your state board of pharmacy, we encourage you to do so as soon as possible in order to be eligible for Pennsylvania licensure. We also encourage you to review your own state's rules regarding the registration, reporting and transfer of intern hours. Please do not hesitate to discuss any questions you have regarding licensure with individual program directors.
Eligible candidates will have completed an ASHP accredited PGY1 pharmacy residency program and must submit the standard application requirements via PhORCAS by January 18th. An on-site interview is required.
To prepare pharmacists to assume any of the following roles:
• Oncology clinical specialist
• Pharmacy educator
Our residents will become confident, effective practitioners of pharmacotherapy. Residents will focus on ensuring application of safe, effective and evidence-based medicine practices to patients with a variety of oncologic and hematologic malignancies in the health system. These practitioners will demonstrate competency in educating their patients as well as present and future health care professionals.
James J. Natale, PharmD BCOP (Director)
John W. Mucenski, PharmD
Timothy Brenner, PharmD, BCOP
Shrina Duggal, PharmD, BCOP
Scott Wirth, PharmD, BCOP
Brian Miller, PharmD